Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) EPS (Weighted Average and Diluted) (2021)

Cogent Biosciences has reported EPS (Weighted Average and Diluted) over the past 1 years, most recently at -$0.62 for Q4 2021.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.62 for Q4 2021, changed N/A from a year ago — trailing twelve months through Sep 2021 was -$1.61 (changed N/A YoY), and the annual figure for FY2025 was -$2.16, down 11.34%.
  • EPS (Weighted Average and Diluted) for Q4 2021 was -$0.62 at Cogent Biosciences, down from -$0.48 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for COGT hit a ceiling of -$0.43 in Q2 2021 and a floor of -$0.62 in Q4 2021.